Brachytherapy in Coronary Artery Disease.
- Author:
Ho Chun SONG
1
Author Information
1. Department of Nuclear Medicine, Chonnam National University Medical School, Gwangju, Korea. songhc@jnu.ac.kr
- Publication Type:Review
- Keywords:
percutaneous coronary intervention;
restenosis;
brachytherapy
- MeSH:
Brachytherapy*;
Coronary Artery Disease*;
Coronary Vessels*;
Drug-Eluting Stents;
Humans;
Hyperplasia;
Models, Animal;
Mortality;
Percutaneous Coronary Intervention;
Radiation, Ionizing;
Thrombosis;
Wound Healing
- From:Nuclear Medicine and Molecular Imaging
2006;40(2):113-119
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Coronary artery disease is a leading cause of morbidity and mortality across the world. Percutaneous coronary intervention has become the major technique of revascularization. However, restenosis remains a major limitation of this procedure. Recently the need for repeat intervention due to restenosis, the most vexing long-term failure of percutaneous coronary intervention, has been significantly reduced owing to the introduction of two major advances, intracoronary brachytherapy and the drug-eluting stents. Intracoronary brachytherapy has been employed in recent years to prevent restenosis lesions with effective results, principally in in-stent restenosis. Restenosis is generally considered as an excessive form of normal wound healing divided up in processes: elastic recoil, neointimal hyperplasia, and negative vascular remodeling. Restenosis has previously been regarded as a proliferative process in which neointimal thickening, mediated by a cascade of inflammatory mediators and other factors, is the key factor. Ionizing radiation has been shown to decrease the proliferative response to injury in animal models of restenosis. Subsequently, several randomized, double-blind trials have demonstrated that intracoronary brachytherapy can reduce the rates of both angiographic restenosis and clinical event rates in patients undergoing percutaneous coronary intervention for in-stent restenosis. Some problems, such as late thrombosis and edge restenosis, have been identified as limiting factors of this technique. Brachytherapy is a promising method of preventing and treating coronary artery restenosis.
